SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-14-000147
Filing Date
2014-02-21
Accepted
2014-02-21 11:52:47
Documents
1
Group Members
DR. ROBERT I. TEPPERKEVIN STARRMARK J. LEVINTHIRD ROCK VENTURES GP L.P.TRV GP LLC

Document Format Files

Seq Description Document Type Size
1 ELEVEN BIOTHERAPEUTICS, INC. eleven-sch13d_17615.htm SC 13D 209830
  Complete submission text file 0001072613-14-000147.txt   211474
Mailing Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116
Business Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116 617-859-3099
THIRD ROCK VENTURES LP (Filed by) CIK: 0001408591 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87951 | Film No.: 14632418
SIC: 2834 Pharmaceutical Preparations